Skip to main content

Abstract

Lithium (Eskalith® and others), a naturally occurring salt, has been used for various medical purposes since the 1800s. Initially, it was given to patients who suffered from urinary calculi and gout. Later, it was combined with bromides and used as a sedative. In 1949, Cade observed that lithium calmed agitated psychotic patients: ten manic patients responded, six schizophrenic and chronically depressed psychotic patients did not, and one patient’s symptoms reappeared after lithium was stopped.1 During this same period, lithium was introduced in the United States as a salt substitute for cardiac patients, but it caused numerous toxic reactions and several deaths. Thus, even with the emergence of convincing evidence that lithium was safe and effective in manic depressive illness, it was not accepted in the United States until 1970.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cade J. F. J.: Lithium salts in the treatment of psychotic excitement. Med J Aust 11:349–352, 1949.

    Google Scholar 

  2. Davis J. M.: Overview: Maintenance therapy in psychiatry: II. Affective disorders. Am J Psychiatry 133:1–13, 1976.

    PubMed  CAS  Google Scholar 

  3. Forn J., Valdecasas F. G.: Effects of lithium on brain adenyl cyclate activity. Biochem Pharmacol 20:2773–2779, 1971.

    Article  PubMed  CAS  Google Scholar 

  4. Gjessing L. R.: Lithium citrate loading of a patient with periodic catatonia. Acta Psychiatr Scand 43:372–375, 1967.

    Article  PubMed  CAS  Google Scholar 

  5. Kline N. S., Wren J. C., Cooper T. B., et al: Evaluation of lithium therapy in chronic and periodic alcoholism. Am J Med Sci 268:15–22, 1974.

    Article  PubMed  CAS  Google Scholar 

  6. Rifkin A., Quitkin F., Carrillo R., et al: Lithium carbonate in emotionally unstable character disorder. Arch Gen Psychiatry 27:519–522, 1972.

    Article  PubMed  CAS  Google Scholar 

  7. Gottfries C. G.: The effect of lithium salts on various kinds of psychiatric disorders. Acta Psychiatr Scand [Suppl] 203:157–167, 1968.

    Article  CAS  Google Scholar 

  8. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed revised (DSM-IIIR). Washington, American Psychiatric Association, 1987.

    Google Scholar 

  9. Nurnberger J R., Roose S. P., Dunner D. L., et al: Unipolar mania: A distinct clinical entity? Am J Psychiatry 136:1420–1423, 1979.

    PubMed  Google Scholar 

  10. Keller M. B., Lavori P. W., Coryell W., et al.: Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 255:3138–3142, 1986.

    Article  PubMed  CAS  Google Scholar 

  11. Winokur G., Clayton P. J., Reich T.: Manic Depressive Disease. St. Louis, C. V. Mosby, 1969.

    Google Scholar 

  12. Weissman M. M., Leaf P. J., Livingston B. M., et al.: The epidemiology of dysthymia in the community: Rates, risks, comorbidity and treatment. 140th Annual Meeting of the American Psychiatric Association, Chicago, American Psychiatric Association, 1987.

    Google Scholar 

  13. Medical Practice Project: A State-of-the-Science Report for the Office of the Assistant Secretary for the U. S. Department of Health, Education and Welfare. Baltimore, Policy Research, 1979.

    Google Scholar 

  14. Fieve R. R.: The lithium clinic: A new model for the delivery of psychiatric services. Am. J Psychiatry 132:1018–1022, 1975.

    PubMed  CAS  Google Scholar 

  15. Garfinkel P. E., Stancer H. C., Persad E.: A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Disord 2:279–288, 1980.

    Article  CAS  Google Scholar 

  16. Prien R. F., Caffey E. M. Jr, Klett C. J.: Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Arch Gen Psychiatry 26:146–152, 1972.

    Article  PubMed  CAS  Google Scholar 

  17. Fieve R. R.: Overview of therapeutic and prophylactic trials with lithium in psychiatric patients, in Gershon S., Shopsin B. (eds): Lithium. Its Role in Psychiatric Research and Treatment. New York, Plenum Press, 1973, p 336.

    Google Scholar 

  18. VanPutten T.: Why do patients with manic-depressive illness stop their lithium? Compr Psychiatry 16:179–183, 1975.

    Article  PubMed  Google Scholar 

  19. Cooper T. B.: Pharmacokinetics of lithium, in Meltzer H. Y. (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp 1365–1376.

    Google Scholar 

  20. Schou M., Anderson A., Eskajaer-Jensen S., et al .: Occurrence of goiter during lithium treatment. Br J Med 3:710–713, 1968.

    Article  CAS  Google Scholar 

  21. Emerson C. H., Dyson W. L., Utiger R. D.: Serum thyrotropin and thyroxin concentration in patients receiving lithium carbonate. J Clin Endocrinol Metab 36:338–346, 1973.

    Article  PubMed  CAS  Google Scholar 

  22. Jefferson J. W.: Lithium carbonate-induced hypothyroidism-its many faces. JAMA 242:271–272, 1979.

    Article  PubMed  CAS  Google Scholar 

  23. VanderVelde C. D., Gordon M. W.: Manic-depressive illness, diabetes mellitus and lithium carbonate treatment. Arch Gen Psychiatry 21:478–485, 1969.

    Article  PubMed  Google Scholar 

  24. Mellerup E. T., Plenge P., Rafaelson O. J. : Renal and other controversial adverse effects of lithium, in Meltzer H. Y. (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp 1443–1448.

    Google Scholar 

  25. Gelenberg A. J.: Lithium-induced polyuria: Approaches to management. Biol Ther Psychiatry Newslett 6:17–19, 1983.

    Google Scholar 

  26. Gelenberg A. J., Wojcik J. D., Falk W. E., et al: Effects of lithium on the kidney. Acta Psychiatr Scand 75:29–34, 1987.

    Article  PubMed  CAS  Google Scholar 

  27. Gelenberg A. J.: Lithium and the nephrotic syndrome. Biol Ther Psychiatry 12:24, 1989.

    Google Scholar 

  28. Shopsin B., Gershon S.: Pharmacology-toxicology of the lithium ion, in Gershon S., Shopsin B. (eds): Lithium: Its Role in Psychiatric Research and Treatment. New York, Plenum Press, 1973, pp 107–146.

    Google Scholar 

  29. Schou M.: Electrocardiographic changes during treatment with lithium and with drugs of the imipramine type. Acta Psychiatr Scand [Suppl] 169:258–259, 1963.

    Article  Google Scholar 

  30. Roose S. P., Nurnberger J. L., Dunner D. L., et al: Cardiac sinus node dysfunction during lithium treatment. Am J Psychiatry 136:804–806, 1979.

    PubMed  CAS  Google Scholar 

  31. Jaffe C. M.: First-degree atrioventricular block during lithium carbonate treatment. Am J Psychiatry 134:88–89, 1977.

    PubMed  CAS  Google Scholar 

  32. Worthley L. J. C.: Lithium toxicity and refractory cardiac arrhythmia treated with intravenous magnesium. Anesth Intens Care 2:357–360, 1974.

    CAS  Google Scholar 

  33. Jefferson J. W., Greist J. H. : Adverse reactions—neurological tremor, in Jefferson, J. W., Greist, J. H. (eds): Primer of Lithium Therapy. Baltimore, Williams & Wilkins, 1977, pp 139–150.

    Google Scholar 

  34. Ghandirian A. M., Lehman H. E.: Neurological side effects of lithium: Organic brain syndrome, seizures, extrapyramidal side effects, and EEG changes. Compr Psychiatry 21:327–335, 1980.

    Article  Google Scholar 

  35. Vestergaard P., Amdison A., Schou M.: Clinically significant side effects of lithium treatment: A survey of 237 patients in long-term treatment. Acta Psychiatr Scand 62:193–200, 1980.

    Article  PubMed  CAS  Google Scholar 

  36. Schou M.: Long-lasting neurological sequelae after lithium intoxication. Acta Psychiatr Scand 70:594–602, 1984.

    Article  PubMed  CAS  Google Scholar 

  37. Gelenberg A. J., Kane J. M., Keller M. B., Lavori P., Rosenbaum J. F., Cole K., Lavelle J.: Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 321:1489–1493, 1989.

    Article  PubMed  CAS  Google Scholar 

  38. Donaldson S. R., Gelenberg A. J., Baldessarini R. J.: The pharmacologic treatment of schizophrenia: A progress report. Schizophrenia Bull 9:504–527, 1983.

    Article  CAS  Google Scholar 

  39. Prien R. F., Gelenberg A. J.: Alternatives to lithium for preventive treatment of bipolar disorder. Am J Psychiatry 146:840–848, 1989.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gelenberg, A.J., Schoonover, S.C. (1991). Bipolar Disorder. In: Gelenberg, A.J., Bassuk, E.L., Schoonover, S.C. (eds) The Practitioner’s Guide to Psychoactive Drugs. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1137-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-1137-0_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-1139-4

  • Online ISBN: 978-1-4757-1137-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics